Biological underpinnings of the commonalities in depression, somatization, and Chronic Fatigue Syndrome

被引:41
作者
Anderson, George [1 ]
Maes, Michael [2 ]
Berk, Michael [3 ,4 ,5 ,6 ]
机构
[1] CRC, Glasgow G11 7QT, Lanark, Scotland
[2] Piyavate Hosp, Bangkok, Thailand
[3] Deakin Univ, Sch Med, Melbourne, Vic, Australia
[4] Ctr Youth Mental Hlth, Orygen Youth Hlth Res Ctr, Parkville, Vic, Australia
[5] Mental Hlth Res Inst Victoria, Parkville, Vic, Australia
[6] Univ Melbourne, Dept Psychiat, Parkville, Vic 3052, Australia
关键词
HORMONAL-REGULATION; QUINOLINIC ACID; KYNURENIC ACID; SYMPTOMS; 2,3-DIOXYGENASE; DISORDER; FEATURES; ANXIETY; STRESS;
D O I
10.1016/j.mehy.2012.02.023
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Somatization is a multisomatoform disorder characterized by medically unexplained, functional or psychosomatic symptoms. Similar somatic symptoms are key components of depression and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Methods: This paper reviews the evidence that such symptoms are organically based. We use the term "physio-somatic" to describe these symptoms. Results: Inflammation, cell-mediated immune (CMI) activation and alterations in the tryptophan catabolite (TRYCAT) pathway are associated with the physio-somatic symptoms of depression, ME/CFS and/or somatization. Proinflammatory cytokines, decreased tryptophan and aberrations in TRYCATs may cause physio-somatic symptoms, such as fatigue, autonomic symptoms, hyperalgesia and somatic presentations. Conclusions: The data suggest co-ordinated and interacting biological pathways driving the occurrence of physio-somatic symptoms across these three disorders, giving a biologically validated "pathway phenotype". These data have far-reaching implications for DSM-IV diagnostic conceptualizations of somatization (and ME/CFS) suggesting the presence of an emerging organic explanation. Future research should focus on the role of immune regulation, and co-ordination, of neuronal activity and, through larger data sets, ultimately creating new, biologically validated classification rules. These data have implications for the development of novel therapies utilizing these insights, buttressing the role of psychotherapy in psychosomatic presentations. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:752 / 756
页数:5
相关论文
共 41 条
[1]  
Anderson G, SOMATIZATION E UNPUB
[2]   Neuronal-immune interactions in mediating stress effects in the etiology and course of schizophrenia: Role of the amygdala in developmental co-ordination [J].
Anderson, George .
MEDICAL HYPOTHESES, 2011, 76 (01) :54-60
[3]  
[Anonymous], 1969, ATTACHMENT LOSS ATTA
[4]   Heterogeneity of serum tryptophan concentration and avaitability to the brain in patients with the chronic fatigue syndrome [J].
Badawy, AAB ;
Morgan, CJ ;
Llewelyn, MB ;
Albuquerque, SRJ ;
Farmer, A .
JOURNAL OF PSYCHOPHARMACOLOGY, 2005, 19 (04) :385-391
[5]   Immune suppression and immune activation in depression [J].
Blume, Joshua ;
Douglas, Steven D. ;
Evans, Dwight L. .
BRAIN BEHAVIOR AND IMMUNITY, 2011, 25 (02) :221-229
[6]  
Burdette S., 2010, Systemic Inflammatory Response Syndrome
[7]  
Chen YQ, 2009, INT J TRYPTOPHAN RES, V2, P1
[8]   G-protein coupled receptor 35 (GPR35) activation and inflammatory pain: Studies on the antinociceptive effects of kynurenic acid and zaprinast [J].
Cosi, Cristina ;
Mannaioni, Guido ;
Cozzi, Andrea ;
Carla, Vincenzo ;
Sili, Maria ;
Cavone, Leonardo ;
Maratea, Dario ;
Moroni, Flavio .
NEUROPHARMACOLOGY, 2011, 60 (7-8) :1227-1231
[9]   SOMATIC SYMPTOM INDEX (SSI) - A NEW AND ABRIDGED SOMATIZATION CONSTRUCT - PREVALENCE AND EPIDEMIOLOGICAL CORRELATES IN 2 LARGE COMMUNITY SAMPLES [J].
ESCOBAR, JI ;
RUBIOSTIPEC, M ;
CANINO, G ;
KARNO, M .
JOURNAL OF NERVOUS AND MENTAL DISEASE, 1989, 177 (03) :140-146
[10]  
HARVEY JA, 1975, FED PROC, V34, P1796